Publication Results (223)

• «
• 1
• 2
• 3
• 4
• 5
• 6
• »

• Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis

  Juurlink DN, Gomes T, Paterson JM, Hellings C, Mamdani MM. CMAJ Open. 2015; 3(4): E428-31.

• Performance of the disease risk score in a cohort study with policy-induced selection bias

  Tadrous M, Mamdani MM, Juurlink DN, Krahn MD, Levesque LE, Cadarette SM. J Comp Eff Res. 2015; 4(6):607-14. Epub 2015 Nov 3.

• Prescription stimulant use and hospitalization for psychosis or mania: a population-based study

  Cressman AM, Macdonald EM, Huang A, Gomes T, Paterson MJ, Kurdyak PA, Mamdani MM, Juurlink DN, Canadian Drug Safety and Effectiveness Research Network. J Clin Psychopharmacol. 2015; 35(6):667-71. Epub 2015 Oct 19.

• Ticagrelor and bradycardia: a nested case-control study

  Turgeon RD, Fernandes KA, Juurlink D, Tu JV, Mamdani M. Pharmacoepidemiol Drug Saf. 2015; 24(12):1281-5. Epub 2015 Oct 7.

• Evaluating the effectiveness of first-line methadone maintenance therapy across northern, rural and urban regions of Ontario, Canada

  Eibl JK, Gomes T, Martins D, Camacho X, Juurlink DN, Mamdani MM, Dhalla IA, Marsh DC. J Addict Med. 2015; 9(6):440-6. Epub 2015 Oct 5.

• Outcomes of daytime procedures performed by attending surgeons after night work

  Govindarajan A, Urbach DR, Kumar M, Li Q, Murray BJ, Juurlink D, Kennedy E, Gagliardi A, Sutradhar R, Baxter NN. N Engl J Med. 2015; 373(9):845-53.

• Sex differences in dose escalation and overdose death during chronic opioid therapy: a population-based cohort study

  Kaplovitch E, Gomes T, Camacho X, Dhalla IA, Mamdani MM, Juurlink D. PLoS One. 2015; 10(8):e0134550. Epub 2015 Aug 20.

• Rates of anomalous bupropion prescriptions in Ontario, Canada

  Steele LS, Macdonald EM, Gomes T, Hollands S, Paterson JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network. Ann Fam Med. 2015; 13(4):343-6.

• A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors

  Cressman AM, Macdonald EM, Fernandes KA, Gomes T, Paterson JM, Mamdani MM, Juurlink DN. Br J Clin Pharmacol. 2015; 80(4):662-9. Epub 2015 Jul 2.

• The impact of policies to reduce blood glucose test strip utilization and costs in Canada

  Gomes T, Martins D, Cheng L, Kratzer J, Juurlink DN, Shah BR, Mamdani MM, Paterson JM, Law MR. Can J Public Health. 2015; 106(4):e210-6.

• Long-term outcomes following self-poisoning in adolescents: a population-based cohort study

  Finkelstein Y, Macdonald EM, Hollands S, Hutson JR, Sivilotti MLA, Mamdani MM, Koren G, Juurlink DN for the Canadian Drug Safety and Effectiveness Research Network (CDSERN). Lancet Psychiatry. 2015; 2(6):532-9. Epub 2015 Apr 25.

• Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study

  Antoniou T, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Garg AX, Paterson JM, Juurlink DN. CMAJ Open. 2015; 3(2):E166-71.

• Predictors of opioid-related death during methadone therapy

  Leece P, Cavacuiti C, Macdonald EM, Gomes T, Kahan M, Srivastava A, Steele L, Luo J, Mamdani MM, Juurlink DN; Canadian Drug Safety Effectiveness Research Network. J Subst Abuse Treat. 2015; 57:30-5. Epub 2015 Apr 15.

• Risk of suicide following deliberate self-poisoning

  Finkelstein Y, Macdonald EM, Hollands S, Sivilotti MLA, Hutson JR, Mamdani MM, Koren G, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN). JAMA Psychiatry. 2015; 72(6):570-5. Epub 2015 Apr 1.

• Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: a population-based study

  Cressman AM, Macdonald EM, Yao Z, Austin PC, Gomes T, Paterson MJ, Kapral MK, Mamdani MM, Juurlink DN. Am Heart J. 2015; 170(1):133-40.e3. Epub 2015 Mar 31.

• Rates of ischemic stroke during warfarin treatment for atrial fibrillation

  Tung JM, Mamdani MM, Juurlink DN, Paterson MJ, Kapral MK, Gomes T. Stroke. 2015; 46(4):1120-2. Epub 2015 Feb 19.

• Neonatal opioid withdrawal and antenatal opioid prescribing

  Turner SD, Gomes T, Camacho X, Yao Z, Guttmann A, Mamdani MM, Juurlink DN, Dhalla IR. CMAJ Open. 2015; 3(1):E55-61. Epub 2015 Feb 11.

• Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based study

  Antoniou T, Yao Z, Camacho X, Mamdani MM, Juurlink DN, Gomes T. Pharmacoepidemiol Drug Saf. 2015; 24(3):256-61. Epub 2015 Feb 5.

• Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone

  Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN). CMAJ. 2015; 187(4):E138-43. Epub 2015 Feb 2.

• Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4

  Li DQ, Kim R, McArthur E, Fleet JL, Bailey DG, Juurlink D, Shariff SZ, Gomes T, Mamdani M, Gandhi S, Dixon S, Garg AX. CMAJ. 2014; 187(3):174-80. Epub 2014 Dec 22.

• Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs: a time series analysis

  Gomes T, Juurlink D, Yao Z, Camacho X, Paterson M, Singh S, Dhalla I, Sproule B, Mamdani M. CMAJ Open. 2014; 2(4):E256-61. Epub 2014 Oct 1.

• Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population-based study

  Fralick M, Macdonald EM, Gomes T, Antoniou T, Hollands S, Mamdani MM, Juurlink DN. BMJ. 2014; 349:g6196. Epub 2014 Oct 30.

• Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study

  Zipursky J, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Paterson JM, Lathia N, Juurlink DN. PLoS Med. 2014; 11(9):e1001736. Epub 2014 Sep 30.

• Trends in high-dose opioid prescribing in Canada

  Gomes T, Mamdani M, Paterson M, Dhalla I, Juurlink D. Can Fam Physician. 2014; 60(9):826-32. Epub 2014 Sep 12.

• Risk of overdose and death following codeine prescription among immigrants

  Ray JG, Hollands S, Gomes T, Urquia ML, Macdonald EM, Li P, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network. J Epidemiol Community Health. 2014; 68(11):1057-63. Epub 2014 Aug 7.

• Extended-release nifedipine and the risk of intestinal obstruction: a population-based study

  Juurlink DN, Hellings C, Gomes T, Huang A, Paterson JM, Urbach DR, Mamdani MM; for the Canadian Drug Safety and Effectiveness Research Network (CDSERN). BMJ Open. 2014; 4(7):e005377. Epub 2014 Jul 24.

• The impact of drug reimbursement policy on rates of testosterone replacement therapy among older men

  Piszczek J, Mamdani M, Antoniou T, Juurlink DN, Gomes T. PLoS One. 2014; 9(7):e98003. Epub 2014 Jul 16.

• The Ontario Drug Policy Research Network: bridging the gap between research and drug policy

  Khan S, Moore JE, Gomes T, Camacho X, Tran J, McAuley G, Juurlink DN, Paterson M, Laupacis A, Mamdani MM. Health Policy. 2014; 117(3):392-8. Epub 2014 Jul 8.

• The burden of premature opioid-related mortality

  Gomes T, Mamdani MM, Dhalla IA, Cornish S, Paterson JM, Juurlink DN. Addiction. 2014; 109(9):1482-8. Epub 2014 Jul 7.

• Recurrence and mortality following severe cutaneous adverse reactions

  Finkelstein Y, Macdonald EM, Li P, Hutson JR, Juurlink DN. JAMA. 2014; 311(21):2231–2. Epub 2014 Jun 4.

• Adverse cardiac events in older patients receiving venlafaxine: a population-based study

  Ho JM, Gomes T, Straus SE, Austin PC, Mamdani M, Juurlink DN. J Clin Psychiatry. 2014;75(6):e552-8.

• Adherence to prescribing recommendations made on a provincial formulary

  Hildebrand AM, Yao Z, Gomes T, Camacho X, Garg AX, Juurlink DN, Mamdani MM, Dhalla IA. Healthc Policy. 2014; 9(4):20-30.

• Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs

  Austin PC, Park-Wyllie LY, Juurlink DN. Pharmacoepidemiol Drug Saf. 2014; 23(8):819-29. Epub 2014 Mar 24.

• Proton pump inhibitors and the risk of adverse cardiac events

  Juurlink DN, Dormuth CR, Huang A, Hellings C, Paterson JM, Raymond C, Kozyrskyj A, Moride Y, Macdonald EM, Mamdani MM. PLoS One. 2013; 8(12):e84890.

• Statins and the risk of herpes zoster: a population-based cohort study

  Antoniou T, Zheng H, Singh S, Juurlink DN, Mamdani MM, Gomes T. Clin Infect Dis. 2014; 58(3):350-6. Epub 2013 Nov 13.

• Comparison of orally administered bisphosphonate drugs in reducing the risk of hip fracture in older adults: a population-based cohort study

  Cadarette SM, Levesque L, Mamdani M, Perreault S, Juurlink DN, Paterson JM, Carney G, Gunraj N, Hawker GA, Tadrous M, Wong L, Dormuth CR. CMAJ Open. 2013; 1(3):E97-105.

• The rise and fall of the thiazolidinediones: impact of clinical evidence publication and formulary change on the prescription incidence of thiazolidinediones

  Hashim S, Gomes T, Juurlink D, Hellings C, Mamdani M. J Popul Ther Clin Pharmacol. 2013; 20(3):238-42. Epub 2013 Sep 6.

• Impact of the JUPITER trial on statin prescribing for primary prevention

  Teng JF, Gomes T, Camacho X, Grundy S, Juurlink DN, Mamdani MM. Pharmacotherapy. 2014; 34(1):9-18. Epub 2013 Aug 12.

• Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions

  Fleet JL, Shariff SZ, Bailey DG, Gandhi S, Juurlink DN, Nash DM, Mamdani M, Gomes T, Patel AM, Garg AX. BMJ Open. 2013; 3:e002857. Epub 2013 Jul 13.

• Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study

  Antoniou T, Camacho X, Yao Z, Gomes T, Juurlink DN, Mamdani MM. CMAJ. 2013; 185(12):1035-41. Epub 2013 Jul 8.

• «
• 1
• 2
• 3
• 4
• 5
• 6
• »